Investigating Rat-Brain Normal Tissue and Tumor FLASH Effects with a Novel Very High Energy Electron Beam
Authors:
- Tyler V. KayTKTyler V. Kay
- Anna L. PriceAPAnna L. Price
- Markus SprengerMSMarkus Sprenger
- Victoria J. P. RadosovaVRVictoria J. P. Radosova
- Andrew ThompsonATAndrew Thompson
- Eric L. MartinEMEric L. Martin
- Denise DunnDDDenise Dunn
- Victor PopovVPVictor Popov
- Stepan MikhailovSMStepan Mikhailov
- Zachary J. ReitmanZRZachary J. Reitman
- Ying K. WuYWYing K. Wu
- Scott R. FloydSFScott R. Floyd
Preprint
Abstract
Purpose: Ultra-high dose rate (FLASH) irradiation is reported to reduce normal tissue toxicity while maintaining tumor control, however mechanism(s) remain obscure. To study FLASH mechanisms in brain tissue, we developed a novel experimental platform featuring a unique high-energy electron linear accelerator (High Intensity Gamma Source, HIGS) paired with an organotypic ex vivo brain metastasis model. Methods: We varied inter-pulse spacing to modulate the mean dose rate (MDR) of our unique 35 MeV electron beam, while maintaining extremely high instantaneous dose rate (IDR), and used film dosimetry to characterize dosimetry and targeting accuracy. We combined this HIGS-FLASH beam with an organotypic rat brain slice/breast carcinoma co-culture model of brain metastasis to assess effects on normal and neoplastic tissues. Live cell and bioluminescence imaging demonstrated cancer cell growth effects, while normal tissue responses and immune activation were assessed with live cell imaging, cytokine profiles, and confocal microscopy. We performed comparison experiments with 20 MeV electrons from a Varian clinical linear accelerator (VCLA) operating at conventional dose rate. Results: The highest IDR of the HIGS-FLASH beam to-date was 20.7 ± 0.6 MGy/s, with maximum MDR of 20.7 MGy/s (1 μs pulse of 20.7 Gy). Beam targeting was accurate to < 1 mm and reproducible. HIGS-FLASH and VCLA dose rates equivalently decreased cancer cell growth. HIGS-FLASH irradiation significantly increased TNFα and fractalkine levels and confocal microscopy revealed distinct changes in microglial morphology in normal brain slices, suggesting microglia activation following HIGS-FLASH irradiation. Conclusions: Our novel experimental platform produces extremely high dose rates and rapid normal/neoplastic tissue readouts for mechanistic research into the effects of FLASH radiation on the brain. HIGS-FLASH irradiation induces comparable cancer cell growth inhibition but differential effects on cytokines and microglial morphology, suggesting that acute innate immune responses may be involved in FLASH normal tissue effects in the brain.Keywords
Funding Information
- NIH/NCI (R21 CA286097)
- NIH/NCI (P30CA014236)
- NIH/NCI (U01TR003715)
This publication has 33 references indexed in Scilit:
- Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone MetastasesJAMA Oncology, 2023
- Quantifying the DNA-damaging Effects of FLASH Irradiation With Plasmid DNAInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- FLASH radiotherapy with photon beamsMedical Physics, 2021
- Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of MicrogliaMolecular Neurobiology, 2020
- Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy SystemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty AwokenClinical Oncology, 2019
- Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/sRadiotherapy and Oncology, 2017
- Organotypic brain slice cultures: A reviewNeuroscience, 2015
- Differential Roles of M1 and M2 Microglia in Neurodegenerative DiseasesMolecular Neurobiology, 2015
- Research opportunities at the upgraded HIγS facilityProgress in Particle and Nuclear Physics, 2009